Patients With Rheumatoid Arthritis Challenged By Complications After Joint Replacement Surgery

Main Category:
Article Date: 30 Nov 2012 – 0:00 PST

Hope For Arthritis Patients ‘Walking On Marbles’

Main Category:
Article Date: 29 Nov 2012 – 1:00 PST

Hope For Arthritis Patients ‘Walking On Marbles’

Researchers at the University of Southampton are to undertake a new stage of a study aimed at improving the health and mobility of those suffering from the common complaint of ‘walking on marbles’ associated with Rheumatoid Arthritis (RA) in the feet.

RA is the second most common form of arthritis in the UK, affecting almost 600,000 people, which results in the destruction of joints around the body caused by inflammation.

Three Times More Women Than Men Suffer From Arthritis: Study Reveals Insights Into This Gender Bias

Main Category: Arthritis / Rheumatology
Also Included In: Genetics;  Women’s Health / Gynecology
Article Date: 19 Nov 2012 – 0:00 PST

Anti-Flammatory Benefits Likely To Be Revealed In Rare Parasitic Fungi

Main Category: Immune System / Vaccines
Also Included In: Respiratory / Asthma;  Arthritis / Rheumatology
Article Date: 17 Nov 2012 – 0:00 PST

Aging Overweight Males At Increased Risk For Gout, Rheumatoid Arthritis

Main Category: Gout
Also Included In: Arthritis / Rheumatology;  Men’s Health;  Seniors / Aging
Article Date: 13 Nov 2012 – 0:00 PST

Aging Overweight Males At Increased Risk For Gout, Rheumatoid Arthritis

Refuting a belief long held by many physicians, a Mayo Clinic study found that rheumatoid arthritis patients also can get gout. The research is among several studies Mayo Clinic presented at the American College of Rheumatology annual meeting in Washington. Researchers also found that gut bacteria has potential to treat autoimmune disorders, rheumatoid arthritis patients are at higher risk for cancer, broken bones put rheumatoid arthritis patients in greater danger of heart disease and death, and corticosteroids are a mainstay of rheumatoid arthritis treatment even as new drugs emerge.
The gout study shows that, contrary to conventional wisdom, rheumatoid arthritis patients aren’t immune to the nation’s obesity-fueled gout epidemic, says lead author Eric Matteson, M.D., chair of the Division of Rheumatology at Mayo Clinic in Rochester, Minn. The two are distinct conditions, treated differently. Rheumatoid arthritis is an autoimmune disease in which the immune system mistakenly attacks tissues, inflaming joints. In gout, the body produces too much uric acid or has problems flushing it out, and urate crystals build up in joints, causing inflammation and intense pain.
The reason it was thought that rheumatoid arthritis patients didn’t get gout likely had to do with the way rheumatoid arthritis used to be treated, Dr. Matteson says. Such patients used to be given aspirin in high doses, and that coincidentally helped their kidneys expel uric acid. Aspirin is no longer used much for rheumatoid arthritis, and that, combined with a rise in obesity, is likely fueling gout in rheumatoid arthritis patients, he says.
“It is probably true that flares of rheumatoid arthritis in some cases might have actually been flares of gout, and that the gout wasn’t diagnosed; it wasn’t realized that it was a coexistent problem,” Dr. Matteson says. “Awareness that gout does exist in patients with rheumatoid arthritis hopefully will lead to better management of gout in those patients.”
Researchers studied 813 patients diagnosed with rheumatoid arthritis between 1980 and 2007 and followed them as long as they were alive and in the county, until last April. The study used the Rochester Epidemiology Project, a National Institutes of Health-supported pool of Olmsted County, Minn., patient medical records from Mayo and other health care providers.
Twenty-two patients developed gout over the study period, most often in the big toe. Gout was more common in patients diagnosed with rheumatoid arthritis from 1995 on. The risk factors for gout were the same as in the general population: being overweight, being older and being male.

The Impact Of Rheumatoid Arthritis And Lupus On Joint Replacement Surgery Outcomes

Main Category: Arthritis / Rheumatology
Also Included In: Lupus;  Bones / Orthopedics
Article Date: 13 Nov 2012 – 0:00 PST

Xeljanz Approved For Rheumatoid Arthritis Treatment By FDA

Editor’s Choice
Main Category: Arthritis / Rheumatology
Also Included In: Bones / Orthopedics;  Regulatory Affairs / Drug Approvals
Article Date: 08 Nov 2012 – 0:00 PST

Xeljanz Approved For Rheumatoid Arthritis Treatment By FDA
Patient / Public: not yet rated
Healthcare Prof:

The U.S. Food and Drug Administration approved a drug by the name of Xeljanz (tofacitinib) for patients who have an insufficient or allergic response to methotrexate, as treatment for fiercely active rheumatoid arthritis.Rheumatoid arthritis (RA) is an autoimmune disease, in which the body’s healthy tissue is under attack by the immune system. This leads to inflammation of the joints and surrounding tissues. RA affects about 1.5 million Americans according to the Centers for Disease Control and Prevention.

Scientists Discover A New Type Of Anti-Inflammatory Drug That Also Works Against Arthritis And Related Conditions

Main Category:
Also Included In: Immune System / Vaccines
Article Date: 03 Nov 2012 – 0:00 PDT

Arthritis Patients’ Lives Improved By Complementary And Alternative Therapy

Main Category: Arthritis / Rheumatology
Also Included In: Complementary Medicine / Alternative Medicine
Article Date: 31 Oct 2012 – 3:00 PDT

Arthritis Patients’ Lives Improved By Complementary And Alternative Therapy
not yet rated
3 stars

3 (1 votes)

ACR Supports Best Practices For Ultrasonography Use In Rheumatology

Main Category: Arthritis / Rheumatology
Also Included In: Lupus;  Gout
Article Date: 31 Oct 2012 – 0:00 PDT

ACR Supports Best Practices For Ultrasonography Use In Rheumatology
Patient / Public: not yet rated
Healthcare Prof: